INSR and metabolic dysfunction-associated steatotic liver disease: NEFA may then accumulate in the liver and initiate non-alcoholic fatty liver disease (NAFLD) [14], and increase concentrations of lipid intermediates that ultimately block the insulin receptor pathway in hepatocytes [11,15].